Stay updated on Napabucasin Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo in Pancreatic Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision: v3.3.2 is now shown on the page, updating from v3.3.1 to reflect a minor document revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.3.1 added and v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check22 days agoChange DetectedThe government funding status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedNo significant changes detected on the Study Details page; the study title, arms, eligibility criteria, primary/secondary outcomes, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedUpdated operating-status notice and version from v3.1.0 to v3.2.0, adding a government funding caveat and links for status details.SummaryDifference1%

- Check72 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical data.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo in Pancreatic Cancer Clinical Trial page.